Continuous glucose monitoring in cystic fibrosis patients according to the glucose tolerance

Hormone and Metabolic Research

Volumn 40, Issue 7, 2008, Pages 502-506

  Moreau, F ^a   Weiller, M A ^a   Rosner, V ^a   Weiss, L ^a,b   Hasselmann, M ^a   Pinget, M ^a   Kessler, R ^a   Kessler, Laurence ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^b CRCM Alsace Centre de Ressources et de Compétances en Mucoviscidose Alsace   (France)

Author keywords

Continuous glucose monitoring; Cystic fibrosis; Cystic fibrosis related diabetes

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGE; AREA UNDER THE CURVE; ARTICLE; BLOOD GLUCOSE MONITORING; BODY MASS; CLINICAL ARTICLE; CONTINUOUS SUBCUTANEOUS BLOOD GLUCOSE MONITORING; CONTROLLED STUDY; CYSTIC FIBROSIS; DIABETES MELLITUS; DIAGNOSTIC VALUE; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TOLERANCE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; MALE; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL;

ADOLESCENT; ADULT; BLOOD GLUCOSE; CIRCADIAN RHYTHM; CYSTIC FIBROSIS; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; MALE; MONITORING, PHYSIOLOGIC; TIME FACTORS;

EID: 48349134989     PISSN: 00185043     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1062723     Document Type: Article

References (24)

1. Lanng S, Thorsteinsson B, Nerup J, Koch C. Influence of the development of diabetes mellitus on clinical status in patients with cystic fibrosis. Eur J Pediatr 1992; 151: 684-687
2. Brennan AL, Geddes DM, Gyi KM, Baker EH. Clinical importance of cystic fibrosis-related diabetes. J Cyst Fibros 2004; 3: 209-222
3. Costa M, Potvin S, Berthiaume Y, Gauthier L, Jeanneret A, Lavoie A, Levesque R, Chiasson JL, Rabasa-Lhoret R. Diabetes: a major co-morbidity of cystic fibrosis. Diabetes Metab 2005; 31: 221-223
4. Moran A, Hardin D, Rodman D, Allen HF, Beall RJ, Borowitz D, Brunzell C, Campbell II, Chesrown SE, Duchow C, Fink RJ, Fitzsimmons SC, Hamilton N, Hirsch I, Howenstine MS, Klein DJ, Zipf WB. Diagnosis, screening and management of cystic fibrosis related diabetes mellitus. A consensus conference report. Diabetes Research and Clinical Practice 1999; 45: 61-73
5. Moran A, Diem P, Klein DJ, Levitt MD, Robertson RP. Pancreatic endocrine function in cystic fibrosis. J Pediatr 1991; 118: 715-723
6. Moran A, Doherty L, Wang X, Thomas W. Abnormal glucose metabolism in cystic fibrosis. J Pediatr 1998; 133: 10-17
7. Yung B, Noormohamed FH, Kemp M, Hooper J, Lant AF, Hodson ME. Cystic fibrosis-related diabetes: the role of peripheral insulin resistance and beta-cell dysfunction. Diabet Med 2002; 19: 221-226
8. Tofé S, Moreno JC, Maiz L, Alonso M, Escobar H, Barrio R. Insulin-secretion abnormalities and clinical deterioration related to impaired glucose tolerance in cystic fibrosis. European J Endocrinol 2005; 152: 241-247
9. Dobson L, Hattersley AT, Tiley S, Elworthy S, Oades PJ, Sheldon CD. Clinical improvement in cystic fibrosis with early insulin treatment. Arch Dis Child 2002; 87: 430-431
10. Kessler L, Passemard R, Oberholzer J, Benhamou PY, Bucher P, Toso C, Meyer P, Penfornis A, Badet L, Wolf P, Colin C, Morel P, Pinget M. Reduction of blood glucose variability in type 1 diabetic patients treated by pancreatic islet transplantation, Interest of continuous glucose monitoring. Diabetes Care 2002; 25: 2256-2262
11. Gross TM, Bode BW, Einhorn D, Kayne DM, Reed JH, White NH. Performance evaluation of the MiniMed continuous glucose monitoring system during home patient use. Diabetes Technol Ther 2000; 2: 49-56
12. Dobson L, Sheldon CD, Hattersley AT. Validation of interstitial fluid continuous glucose monitoring in cystic fibrosis. Diabetes Care 2003; 26: 1940-1941
13. Brennan AL, Gyi KM, Wood DM, Johnson J, Holliman R, Baines DL, Philips BJ, Hodson ME, Geddes DM, Baker EH. Airway glucose concentrations and effect on growth of respiratory pathogens in cystic fibrosis. J Cyst Fibros 2007; 6: 101-109
14. Jefferies C, Solomon M, Perlman K, Sweezey N, Daneman D. Continuous glucose monitoring in adolescents with cystic fibrosis. J Pediatr 2005; 147: 396-398
15. Mastrototaro J. The Minimed continuous glucose monitoring system (CGMS). J Pediatric Endocrinol Metab 1999; 12: 751-758
16. Rebrin K, Steil GM, Antwerp WP Van. Subcutaneous glucose predicts plasma glucose independent of insulin: implication for continuous monitoring. Am J Physiol 1999; 277: 561-571
17. Marshall BC, Butler SM, Stoddard M, Moran AM, Liou TG, Morgan WJ. Epidemiology of cystic fibrosis-related diabetes. J Pediatr 2005; 146: 681-687
18. Dobson L, Hattersley AT, Tiley S, Elworthy S, Oades PJ, Sheldon CD. Conventional measures underestimate glycaemia in cystic fibrosis patients. Diabet Med 2004; 21: 691-696
19. Rafii M, Chapman K, Stewart C, Kelly F, Hanna A, Wilson DC, Tullis E, Pencharz PB. Changes in response to insulin and the effects of varying glucose tolerance on whole-body protein metabolism in patients with cystic fibrosis. Am J Clin Nutr 2005; 81: 421-426
20. Wagener JS, MacNeill GC, Taussig LM, Corrigan JJ, Lemen R. Ferrokinetic and hematologic studies in cystic fibrosis patients. Am J Pediatr Hematol Oncol 1983; 5: 143-160
21. Brennan AL, Gyi KM, Wood DM, Hodson ME, Geddes DM, Baker EH. Relationship between glycosylated haemoglobin and mean plasma glucose concentration in cystic fibrosis. Journal of Cystic Fibrosis 2006; 5: 27-31
22. Pistrosch F, Koehler C, Wildbrett J. Hanefelg M. Relationship between diurnal glucose levels and HbA1c in type 2 diabetes. Horm Metab Res 2006; 38: 455-459
23. Bizzarri C, Lucidi V, Ciampalini P, Bella S, Russo B, Cappa M. Clinical effects of early treatment with insulin glargine in patients with cystic fibrosis and impaired glucose tolerance. J Endocrinol Invest 2006; 29: 1-4
24. Rolon MA, Benali K, Munck A, Navarro J, Clement A, Tubiana-Rufi N et al. Cystic fibrosis-related diabetes mellitus: clinical impact of prediabetes and effects of insulin therapy. Acta Paediatr 2001; 90: 860-867